BioInvent and Transgene to present preclinical data on BT-001 oncolytic virus at SITC 2021

LUND, SE / ACCESSWIRE / October 1, 2021 / BioInvent International (STO:BINV)BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory …